Goldman Sachs’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $93.4K | Buy |
|
|||||
|
2022
Q4 | $47.7K | Sell |
|
|||||
|
2022
Q3 | $200K | Sell |
|
|||||
|
2022
Q2 | $177K | Sell |
|
|||||
|
2022
Q1 | $772K | Buy |
|
|||||
|
2021
Q4 | $1.14M | Sell |
|
|||||
|
2021
Q3 | $1.32M | Buy |
|
|||||
|
2021
Q2 | $1.74M | Buy |
|
|||||
|
2021
Q1 | $1.73M | Sell |
|
|||||
|
2020
Q4 | $1.55M | Buy |
|
|||||
|
2020
Q3 | $846K | Sell |
|
|||||
|
2020
Q2 | $1.18M | Buy |
|
|||||
|
2020
Q1 | $681K | Sell |
|
|||||
|
2019
Q4 | $1.38M | Buy |
|
|||||
|
2019
Q3 | $572K | Buy |
|
|||||
|
2019
Q2 | $158K | Sell |
|
|||||
|
2019
Q1 | $359K | Sell |
|
|||||
|
2018
Q4 | $421K | Buy |
|
|||||
|
2018
Q3 | $381K | Sell |
|
|||||
|
2018
Q2 | $1.68M | Buy |
|
|||||
|
2018
Q1 | $659K | Buy |
|
|||||
|
2017
Q4 | $847K | Sell |
|
|||||
|
2017
Q3 | $3.15M | Sell |
|
|||||
|
2017
Q2 | $3.17M | Buy |
|
|||||
|
2017
Q1 | $837K | Sell |
|
|||||
|
2016
Q4 | $841K | Sell |
|
|||||
|
2016
Q3 | $719K | Sell |
|
|||||
|
2016
Q2 | $992K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $365K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $83K | Sell |
|
|||||
|
2013
Q2 | $80K | Buy |
|